Hexaminolevulinate Hydrochloride

盐酸六氨基-γ-酮戊酸

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameHexaminolevulinate Hydrochloride
Drug Alias Name盐酸黑克斯胺5-ALA hexylesther盐酸六氨基乙酰丙酸hexaminolevulinate盐酸氨酮戊酸己酯 +[28] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsSquamous Intraepithelial Lesions of the CervixUrinary Bladder NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsUrinary Bladder Neoplasms
Approved Indications in ChinaUrinary Bladder Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryMainland China(BOAO LECHENG)CanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPhotocure
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yahong Pharmaceutical Technology Co LtdAsieris Meditech (Hong Kong) Co LtdEquity Pharmaceuticals PTY Ltd +[8] 
Inactive CompaniesPhotocureBioglan AbJohns Hopkins University
Active IndicationsSquamous Intraepithelial Lesions of the CervixUrinary Bladder NeoplasmsCervical Intraepithelial Neoplasia
Inactive IndicationsColonic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeV04CX
Related LinksDrugBankKEGG